Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001014100-08-000039
Filing Date
2008-04-02
Accepted
2008-04-02 12:47:26
Documents
1
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 sta7.html 4  
1 sta7.xml 4 3875
  Complete submission text file 0001014100-08-000039.txt   5927
Mailing Address 2200 WILSON BLVD. SUITE 102-316 ARLINGTON VA 22201
Business Address 2200 WILSON BLVD SUITE 102-316 ARLINGTON VA 22201 703-526-0400
CHAMPIONS BIOTECHNOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014
Business Address 6466385078
Stancic Ana (Reporting) CIK: 0001320271 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17263 | Film No.: 08732241